Jeffrey W. Albers Blueprint Medicines Corp (BPMC) insider trading activity
Jeffrey W. Albers is Director of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Mar 04, 2021, when has been sold 10,000 shares (Common Stock) at a price of $8.8 per share, resulting in proceeds of $88,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
100.0%
3M change
100.0%
12M change
Total Value Held
$0
Jeffrey W. Albers Transaction History
Also insider at
JWA
Jeffrey W. Albers
Director
Cambridge, MA